TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

ACTOPLUS MET

METFORMIN HYDROCHLORIDE
Approved 2005-08-29
3
Indications
--
Phase 3 Trials
20
Years on Market

Details

Status
Discontinued
First Approved
2005-08-29
Routes
ORAL
Dosage Forms
TABLET

ACTOPLUS MET Approval History

Loading approval history...

What ACTOPLUS MET Treats

3 FDA approvals

Originally approved for its first indication in 2005 . Covers 3 distinct patient populations.

  • Other (3)
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

ACTOPLUS MET FDA Label Details

Pro

ACTOPLUS MET Patents & Exclusivity

Latest Patent: Feb 2029

Patents (8 active)

US9320714 Expires Feb 3, 2029
US9101660 Expires Jan 22, 2027
Source: FDA Orange Book

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.